Tas, F., Ozturk, A., & Erturk, K. (2025). Clinical significances of TTF-1, neuroendocrine (chromogranin, synaptophysin, CD56), and keratin (pancytokeratin, CK7, CK5/6) marker immunostaining in small cell lung cancer. Clinical and Translational Oncology, 27(3), 1075-1083. https://doi.org/10.1007/s12094-024-03683-2
Chicago Style (17th ed.) CitationTas, Faruk, Akin Ozturk, and Kayhan Erturk. "Clinical Significances of TTF-1, Neuroendocrine (chromogranin, Synaptophysin, CD56), and Keratin (pancytokeratin, CK7, CK5/6) Marker Immunostaining in Small Cell Lung Cancer." Clinical and Translational Oncology 27, no. 3 (2025): 1075-1083. https://doi.org/10.1007/s12094-024-03683-2.
MLA (9th ed.) CitationTas, Faruk, et al. "Clinical Significances of TTF-1, Neuroendocrine (chromogranin, Synaptophysin, CD56), and Keratin (pancytokeratin, CK7, CK5/6) Marker Immunostaining in Small Cell Lung Cancer." Clinical and Translational Oncology, vol. 27, no. 3, 2025, pp. 1075-1083, https://doi.org/10.1007/s12094-024-03683-2.